{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T11:06:23Z","timestamp":1777633583704,"version":"3.51.4"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>HIV-associated diffuse large B-cell lymphoma (DLBCL) is an aggressive malignancy with poor outcomes despite combination antiretroviral therapy (cART). Spontaneous regression in advanced-stage disease is exceptionally rare.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case description<\/jats:title>\n                    <jats:p>A 66-year-old male with stage IV, non-germinal center DLBCL involving the liver achieved complete radiographic resolution of multifocal hepatic lesions without cytotoxic therapy following cART initiation. Remission has been sustained for over 36 months. Effective viral suppression and CD4+ T-cell recovery (from 200 to 571 cells\/\u03bcL) were temporally correlated with tumor regression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Spontaneous regression of stage IV diffuse large B\u2212cell lymphoma (DLBCL) is exceedingly rare among individuals with HIV infection. This case underscores the critical role of immune reconstitution via cART in treating HIV\u2212associated lymphoma. Therefore, it is recommended to initiate cART as early as possible in HIV\u2212positive lymphoma patients to restore immune function, which can positively influence lymphoma management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1779897","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T04:44:44Z","timestamp":1777437884000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Spontaneous regression of stage IV advanced diffuse large B-cell lymphoma in an person living with HIV: a case report and literature review"],"prefix":"10.3389","volume":"16","author":[{"given":"Wei","family":"Zhang","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Chongqing Public Health Medical Center","place":["Chongqing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changgang","family":"Deng","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Chongqing Public Health Medical Center","place":["Chongqing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qisui","family":"Li","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Chongqing Public Health Medical Center","place":["Chongqing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Yuan","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Chongqing Public Health Medical Center","place":["Chongqing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)31311-4","article-title":"HIV","volume":"392","author":"Ghosn","year":"2018","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e318246b862","article-title":"Trends in reasons for hospitalization in a multisite United States cohort of persons living with HIV, 2001-2008","volume":"59","author":"Berry","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1056\/NEJMc1804812","article-title":"HIV-associated cancers and related diseases","volume":"378","author":"Yarchoan","year":"2018","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1182\/blood.2020005469","article-title":"Hematologic cancers in individuals infected by HIV","volume":"139","author":"Carbone","year":"2022","journal-title":"Blood"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.13419\/j.cnki.aids.2021.11.02","article-title":"Chinese guidelines for diagnosis and treatment of HIV\/AIDS (2021 edition)","volume":"27","year":"2021","journal-title":"Zhonghua AIDS Xingbing"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-01-791400","article-title":"Optimizing treatment of HIV-associated lymphoma","volume":"134","author":"Noy","year":"2019","journal-title":"Blood"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16030546","article-title":"Cancer and HIV: The molecular mechanisms of the deadly duo","volume":"16","author":"Omar","year":"2024","journal-title":"Cancers (Basel)"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1361009","article-title":"Carcinogenic mechanisms of virus-associated lymphoma","volume":"15","author":"Zhang","year":"2024","journal-title":"Front Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.00022-23","article-title":"HIV-associated cancers and lymphoproliferative disorders caused by Kaposi sarcoma herpesvirus and Epstein-Barr virus","volume":"37","author":"Lurain","year":"2024","journal-title":"Clin Microbiol Rev"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020005470","article-title":"KSHV\/HHV8-mediated hematologic diseases","volume":"139","author":"Cesarman","year":"2022","journal-title":"Blood"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.4084\/MJHID.2019.004","article-title":"Hiv and lymphoma: From epidemiology to clinical management","volume":"11","author":"Re","year":"2019","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(19)30039-6","article-title":"Non-Hodgkin lymphoma in people with HIV","volume":"6","author":"Aboulafia","year":"2019","journal-title":"Lancet HIV"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.32970","article-title":"The spontaneous regression of primary gastrointestinal malignancies: An observational review","volume":"14","author":"Minacapelli","year":"2022","journal-title":"Cureus"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0000000000000236","article-title":"Spontaneous regression of non-small-cell lung cancer in AIDS after immune reconstitution","volume":"10","author":"Menon","year":"2015","journal-title":"J Thorac Oncol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.6639","article-title":"Spontaneous regression of non-small cell lung cancer: A case report and literature review","volume":"12","author":"Shatola","year":"2020","journal-title":"Cureus"},{"key":"B16","doi-asserted-by":"publisher","first-page":"30397","DOI":"10.1038\/s41598-024-80749-9","article-title":"Survival of HIV associated diffuse large B-cell lymphoma and Burkitt lymphoma in China","volume":"14","author":"Xiong","year":"2024","journal-title":"Sci Rep"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15123191","article-title":"Diffuse large B-cell lymphoma in the HIV setting","volume":"15","author":"Huguet","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2024.286343","article-title":"Survival outcomes in diffuse large B-cell lymphoma patients with and without HIV in the United States from 2001 to 2016: a population-based analysis","volume":"110","author":"Valcarcel","year":"2025","journal-title":"Haematologica"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2015.1131276","article-title":"Remission of human immunodeficiency virus-related lymphoma in association with immune reconstitution on anti-retroviral therapy, without chemotherapy","volume":"57","author":"Griffin","year":"2016","journal-title":"Leuk Lymphoma"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1177\/0956462416686512","article-title":"Stage IV advanced diffuse large B-cell lymphoma in human immunodeficiency virus infection with achieving cure by using highly active antiretroviral therapy alone: A case report","volume":"28","author":"Lim","year":"2017","journal-title":"Int J STD AIDS"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.23937\/2378-3419\/1410127","article-title":"Spontaneous regression of hepatic diffuse large B-cell lymphoma in HIV and HCV positive patient: A novel case study","author":"Alhatem","year":"2019","journal-title":"Int J Clin Case Rep"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.55790","article-title":"Spontaneous regression of Epstein-Barr virus-positive diffuse large B-cell lymphoma in an HIV-positive patient: A case report and literature review","volume":"16","author":"Khaw","year":"2024","journal-title":"Cureus"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adk2091","article-title":"IRF8-mutant B cell lymphoma evades immunity through a CD74-dependent deregulation of antigen processing and presentation in MHCII complexes","volume":"10","author":"Qiu","year":"2024","journal-title":"Sci Adv"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3390\/cells13020128","article-title":"Development of innate-immune-cell-based immunotherapy for adult T-cell leukemia-lymphoma","volume":"13","author":"Nakashima","year":"2024","journal-title":"Cells"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.29423","article-title":"Chronic HIV-1 Tat action induces HLA-DR downregulation in B cells: A mechanism for lymphoma immune escape in people living with HIV","volume":"96","author":"Shmakova","year":"2024","journal-title":"J Med Virol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1101\/2024.11.30.626166","article-title":"Systems biology-enabled targeting of NF-\u03baB and BCL2 overcomes microenvironment-mediated BH3-mimetic resistance in DLBCL","volume":"2024","author":"Vareli","year":"2024","journal-title":"bioRxiv"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1177\/1747493018778713","article-title":"Multisociety Consensus Quality Improvement Revised Consensus Statement for Endovascular Therapy of Acute Ischemic Stroke","volume":"13","author":"Sacks","year":"2018","journal-title":"Int J Stroke"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/hem3.150","article-title":"Human immunodeficiency virus-associated lymphomas: EHA-ESMO clinical practice guideline for diagnosis, treatment and follow-up","volume":"8","author":"H\u00fcbel","year":"2024","journal-title":"Hemasphere"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1111\/hiv.13514","article-title":"Enabling CAR T-cell therapies for HIV-positive lymphoma patients - A call for action","volume":"24","author":"Hattenhauer","year":"2023","journal-title":"HIV Med"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1779897\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T04:45:01Z","timestamp":1777437901000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1779897\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":29,"alternative-id":["10.3389\/fonc.2026.1779897"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1779897","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,29]]},"article-number":"1779897"}}